GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE83549 Query DataSets for GSE83549
Status Public on Mar 06, 2017
Title RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary To determine how targeting the disruption of PRC2:SMN-AS1 interactions might affect PRC2 targets globally, we performed RNA-sequencing after transfection of a PRC2:SMN-AS1 targeting mixmer oligo, RN-0005, an antisense gapmer oligonucleotide targeting SUZ12, a subunit of the PRC2 complex, or mock in SMA fibroblasts. Via RT-qPCR, treatment with either the mixmer oligo or the SUZ12 gapmer for 2 and 3 days results in significant increases of SMN mRNA levels compared to transfection control samples. We sequenced total RNA from 12 GM09677 fibroblast samples split into two day or three day treatments (6 samples each). Within each set of six samples, there were 2 mock control replicates, 2 mixmer replicates, and 2 SUZ12kd-gapmer replicates. By controlling for time and looking at the two treatments versus mock samples, we identified the genes that change when knocking down PRC2 systemically with a gapmer versus more specifically blocking PRC2 activity with a mixmer oligo targeting the SMN2-AS1 lncRNA.
Overall design Mock, RN-0005 mixmer, and the SUZ12-KD gapmer treated SMA fibroblasts were sequenced. For each of the treatments, there were two time points with each time point having two replicates for a total number of 4 samples per condition. Gene expression differences were identified for the contrasts of RN-0005 vs. mock and SUZ12-KD vs. mock after fitting to a linear model blocking for time.
Contributor(s) Brothers JF, Woo CJ
Citation(s) 28193854
Submission date Jun 20, 2016
Last update date May 15, 2019
Contact name Caroline J. Woo
Phone 8572423425
Organization name RaNA Therapeutics Inc.
Street address 200 Sidney Street
City Cambridge
State/province Massachusetts
ZIP/Postal code 02139
Country USA
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (12)
GSM2209014 mock_01
GSM2209015 mock_02
GSM2209016 RN-0005_01
BioProject PRJNA326313
SRA SRP076885

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE83549_RAW.tar 2.8 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap